Surendralal Lanca Karsanbhai - 13 Nov 2025 Form 4 Insider Report for EMERSON ELECTRIC CO (EMR)

Role
President & CEO, Director
Signature
/s/ John A. Sperino, Attorney-in-Fact for Surendralal Lanca Karsanbhai
Issuer symbol
EMR
Transactions as of
13 Nov 2025
Transactions value $
$0
Form type
4
Filing time
14 Nov 2025, 16:31:10 UTC
Previous filing
10 Nov 2025
Next filing
26 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Karsanbhai Surendralal Lanca President & CEO, Director C/O EMERSON ELECTRIC CO., 8027 FORSYTH BLVD., ST. LOUIS /s/ John A. Sperino, Attorney-in-Fact for Surendralal Lanca Karsanbhai 14 Nov 2025 0001754881

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EMR Employee Stock Option (Right to Buy) Award +70K 70K 13 Nov 2025 Common Stock 70K $128.46 Direct F1, F2, F3
transaction EMR Employee Stock Option (Right to Buy) Award +70K 70K 13 Nov 2025 Common Stock 70K $160.58 Direct F1, F2, F3, F4
transaction EMR Employee Stock Option (Right to Buy) Award +70K 70K 13 Nov 2025 Common Stock 70K $192.69 Direct F1, F2, F3, F5
transaction EMR Employee Stock Option (Right to Buy) Award +70K 70K 13 Nov 2025 Common Stock 70K $224.81 Direct F1, F2, F3, F6
transaction EMR Employee Stock Option (Right to Buy) Award +70K 70K 13 Nov 2025 Common Stock 70K $256.92 Direct F1, F2, F3, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of stock options under shareholder approved benefit plan exempt pursuant to Rule 16b-3(d).
F2 The Reporting person was awarded a total of 350,000 stock options on 11/13/2025 in 5 tranches of 70,000 stock options each, with each tranche having a different exercise price. Each of the 5 tranches of 70,000 stock options become exercisable in five equal annual installments of 14,000 each beginning on 11/13/2026.
F3 Price is not applicable to stock options received as incentive compensation.
F4 The exercise price is equal to 125% of the closing price of Issuer's common stock on the date of grant.
F5 The exercise price is equal to 150% of the closing price of Issuer's common stock on the date of grant.
F6 The exercise price is equal to 175% of the closing price of Issuer's common stock on the date of grant.
F7 The exercise price is equal to 200% of the closing price of Issuer's common stock on the date of grant.